Anti-ATG13 monoclonal antibody

Pre-made anti-ATG13 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ATG13/ATG13 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2364-Ab-1/ GM-Tg-hg-IP2364-Ab-2Anti-Human ATG13 monoclonal antibodyHuman
GM-Tg-rg-IP2364-Ab-1/ GM-Tg-rg-IP2364-Ab-2Anti-Rat ATG13 monoclonal antibodyRat
GM-Tg-mg-IP2364-Ab-1/ GM-Tg-mg-IP2364-Ab-2Anti-Mouse ATG13 monoclonal antibodyMouse
GM-Tg-cynog-IP2364-Ab-1/ GM-Tg-cynog-IP2364-Ab-2Anti-Cynomolgus/ Rhesus macaque ATG13 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2364-Ab-1/ GM-Tg-felg-IP2364-Ab-2Anti-Feline ATG13 monoclonal antibodyFeline
GM-Tg-cang-IP2364-Ab-1/ GM-Tg-cang-IP2364-Ab-2Anti-Canine ATG13 monoclonal antibodyCanine
GM-Tg-bovg-IP2364-Ab-1/ GM-Tg-bovg-IP2364-Ab-2Anti-Bovine ATG13 monoclonal antibodyBovine
GM-Tg-equg-IP2364-Ab-1/ GM-Tg-equg-IP2364-Ab-2Anti-Equine ATG13 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2364-Ab-1/ GM-Tg-hg-IP2364-Ab-2; GM-Tg-rg-IP2364-Ab-1/ GM-Tg-rg-IP2364-Ab-2;
GM-Tg-mg-IP2364-Ab-1/ GM-Tg-mg-IP2364-Ab-2; GM-Tg-cynog-IP2364-Ab-1/ GM-Tg-cynog-IP2364-Ab-2;
GM-Tg-felg-IP2364-Ab-1/ GM-Tg-felg-IP2364-Ab-2; GM-Tg-cang-IP2364-Ab-1/ GM-Tg-cang-IP2364-Ab-2;
GM-Tg-bovg-IP2364-Ab-1/ GM-Tg-bovg-IP2364-Ab-2; GM-Tg-equg-IP2364-Ab-1/ GM-Tg-equg-IP2364-Ab-2
Products NameAnti-ATG13 monoclonal antibody
Formatmab
Target NameATG13
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ATG13 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2364-Ag-1Recombinant multi-species ATG13/ KIAA0652/ PARATARG8 protein


    Target information

    Target IDGM-IP2364
    Target NameATG13
    Gene ID9776,51897,362164,714322,483632,101089141,507340,100050734
    Gene Symbol and Synonyms1110053A20Rik,ATG13,D2Ertd391e,Harbi1,Harbi1l,KIAA0652,PARATARG8,RGD1310685
    Uniprot AccessionO75143,Q08DY8
    Uniprot Entry NameATG13_HUMAN,ATG13_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000175224
    Target ClassificationN/A

    The target: ATG13, gene name: ATG13, also named as KIAA0652, PARATARG8. The protein encoded by this gene is an autophagy factor and a target of the TOR kinase signaling pathway. The encoded protein is essential for autophagosome formation and mitophagy. [provided by RefSeq, Oct 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.